- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05417347
Full-fat Dairy Products, Body Weight Control and Metabolic Health
October 3, 2023 updated by: Vicky Drapeau, Laval University
he Role of Full-fat Dairy Products on Body Weight Control and Metabolic Health in Adults and Children
The aim of this research is to clarify the role of different dairy products including both full-fat and low-fat dairy in maintaining health in adults and children through its effects beyond their well-known contribution of healthy nutrients.
The deleterious health consequences of obesity are recognized as a major financial burden to health care systems.
Diets rich in fruits and vegetables and that also include dairy products have been suggested to play a role in the control of body weight and other aspects of health including the maintenance of healthy gut bacteria.
In contrast, full-fat diets, especially those high in saturated fat, have been linked with negative health effects.
Although dairy products represent an important source of saturated fat, it has been proposed that the combination of nutrients and complex food forms of the various dairy products may in fact counteract the negative effects of the fat.
Thus, increased consumption of dairy products could very likely provide a partial dietary solution to improved body weight and metabolic health.
Therefore, we are investigating the role of both full-fat and low-fat dairy products in their different physical forms (i.e.
varying levels of fat that contribute to different textures) on appetite, food intake, control of blood sugar (glucose), body weight, cholesterol levels, and blood pressure in both children and adults.
Existing dairy products (milk, cheese, and yogurt) ranging in fat content will be compared for their effects on satiety, food intake, glucose, insulin, satiety hormones, gut bacteria and other metabolic parameters linked to cardiometabolic health in normal weight children and adults, as well as in children and adults living with overweight and obesity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The overall objective is to examine the long-term effects of full-fat dairy products on appetite and body weight control, diet quality, and metabolic health in adults living with obesity (18-55 y) and in children (8-16 y).
This project also aims to identify some key mechanisms (i.e.
gut peptides, gut microbiota) involved in the beneficial impact of dairy products on these outcomes.
This study aims to evaluate the impact of a web-based nutrition intervention integrating full-fat or low-fat dairy products into the diets of families (at least one parent with BMI >30 kg/m2) under free-living conditions, on overall dairy consumption, body weight and composition, diet quality, eating and psychobehavioural traits and cardiometabolic outcomes, in normal weight/obese adults and children.
This is a randomized, controlled, single-blind study consisting of three parallel groups.
Families (n=25/group) will be randomized to either an intervention promoting either 1) low-fat or 2) full-fat dairy) or 3) control group (no intervention but same follow-up) over an 8-week period.
The nutrition intervention aims to increase the quantity and variety of dairy products (i.e.
low and full-fat milk, yogurt and cheese) in the diet.
Evaluation periods for each family will be conducted before the study (week 0 in the lab), at the end (week 9 at home) and after 3 months (week 20 at home) after the intervention.
Measurements include anthropometry, fasting lipid and glycemic profiles, diet quality, eating and psychobehavioral traits and food reward/appreciation/acceptance.
The proposed research will provide timely data required to support recommendations to consume low and full-fat dairy products in individuals living with obesity, particularly during weight loss and maintenance.
It will also provide the basis for family interventions that have the potential to positively impact diet quality and dairy consumption.
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lucie Brunelle, MSc, RD
- Phone Number: 406721 4186562131
- Email: lucie.brunelle@kin.ulaval.ca
Study Contact Backup
- Name: Shirin Panahi, PhD
- Phone Number: 406721 4186562131
- Email: spanahi329@gmail.com
Study Locations
-
-
Quebec
-
Quebec City, Quebec, Canada, G1V0A6
- Recruiting
- Laval University
-
Contact:
- Lucie Brunelle, MSc, RD
- Phone Number: 406721 4186562131
- Email: lucie.brunelle@kin.ulaval.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 53 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Parent criteria are as follows:
- men and women between 18-55 years
- body mass index (BMI) between 30-40 kg/m2
- absence of pregnancy, breastfeeding or menopause (no menstruation)
- stable body weight (weight change <5 kg for three months prior to screening).
Family criteria are as follows:
- being a family composed of at least one parent (mother/father) and at least two children between 8 to 16 years old (families between 3 to 5 persons). Families with at least one obese parent (BMI between 30-40 kg/m2) will be recruited since children coming from these families are more at risk of developing obesity and may benefit more from dairy products
- all participants should have no allergies to dairy products or lactose intolerance and be in good general health.
- since we are recruiting adults with obesity and dairy products may positively impact several metabolic markers, those with hypertension or deteriorated blood glucose and lipid profiles and/or taking medications will also be considered.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Low-fat dairy products
Consumption of low-fat dairy products (4 servings/day with 2 servings/day coming from yogurt)
|
Milk: low fat (less than 2% M.F.) Yogurt: less than 2% M.F.
Cheese: less than 20% M.F.
|
Active Comparator: Full-fat dairy products
Consumption of high-fat dairy products (4 servings/day with 2 servings/day coming from yogurt)
|
Milk: full-fat milk Yogurt: 2% and more M.F.
Cheese: Regular cheese products
|
No Intervention: Control
Will be recommended to choose low-fat dairy products and alternatives based on recommendations from the 2007 Canadian Food Guide (2 servings/day for adults and 3-4 servings/day for children)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dairy consumption
Time Frame: 8 weeks
|
# of servings of dairy
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight (kg)
Time Frame: week 0, week 9, week 24
|
Body weight will be measured using standard laboratory methods
|
week 0, week 9, week 24
|
Systolic and diastolic blood pressure (mmHg)
Time Frame: week 0, week 9, week 24
|
Blood pressure will be measured using standard laboratory methods
|
week 0, week 9, week 24
|
Plasma lipids (total cholesterol, HDL and LDL cholesterol, triglycerides)
Time Frame: week 0, week 9, week 24
|
Plasma lipids will be measured using standard laboratory methods
|
week 0, week 9, week 24
|
Gastrointestinal peptides and hormones
Time Frame: week 0, week 9, week 24
|
The following hormones will be measured: adiponectin, amylin, leptin, ghrelin, glucose insulinotropic peptide (GIP), glucagon-like peptide (GLP-1), peptide tyrosine tyrosine (PYY), cortisol
|
week 0, week 9, week 24
|
Oral microbiota (bacterial DNA from saliva)
Time Frame: week 0, week 9, week 24
|
Saliva samples will be collected.
|
week 0, week 9, week 24
|
Habitual food intake and diet quality
Time Frame: week 0, week 9, week 24
|
24-h web-based dietary recalls
|
week 0, week 9, week 24
|
Eating behaviours
Time Frame: week 0, week 9, week 24
|
Various validated questionnaires (e.g.
Three-Factor Eating Questionnaire and Child Three-Factor Eating Questaionnaire) will be used to assess these traits
|
week 0, week 9, week 24
|
Physical activity
Time Frame: week 0, week 9, week 24
|
Physical activity diary
|
week 0, week 9, week 24
|
Cravings
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the State/Trait Food Cravings Questionnaire to examine eating behaviour traits and factors which could influence appetite control and metabolic variables such as restraint behaviour and sleep deprivation.
Each parent will complete the child's feeding questionnaire and the caregiver feeding style questionnaire to assess parental feeding practices.
|
week 0, week 9, week 24
|
Sleeping Habits
Time Frame: week 0, week 9, week 24
|
Pittsburgh Sleep Quality Index Questionnaire
|
week 0, week 9, week 24
|
Resting metabolic rate
Time Frame: week 0, week 9, week 24
|
Indirect calorimetry will be used
|
week 0, week 9, week 24
|
Binge Eating Tendencies
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the Binge Scale to examine eating behaviour traits and factors which could influence appetite control and metabolic variables such as restraint behaviour and sleep deprivation.
Each parent will complete the child's feeding questionnaire and the caregiver feeding style questionnaire to assess parental feeding practices.
|
week 0, week 9, week 24
|
Cognitive restraint, disinhibition, susceptibility to hunger
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the Three Factor Eating Questionnaire to examine eating behaviour traits and factors which could influence appetite control and metabolic variables such as restraint behaviour and sleep deprivation.
Each parent will complete the child's feeding questionnaire and the caregiver feeding style questionnaire to assess parental feeding practices.
|
week 0, week 9, week 24
|
Distress-related body esteem
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the Body Esteem Scale to examine eating behaviour traits and factors which could influence appetite control and metabolic variables such as restraint behaviour and sleep deprivation.
Each parent will complete the child's feeding questionnaire and the caregiver feeding style questionnaire to assess parental feeding practices.
|
week 0, week 9, week 24
|
Depression symptoms
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the Beck Depression Inventory.
|
week 0, week 9, week 24
|
Anxiety symptoms
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the State-Trait Anxiety Inventory.
|
week 0, week 9, week 24
|
Stress levels
Time Frame: week 0, week 9, week 24
|
All adult participants will complete the Perceived Stress Scale.
|
week 0, week 9, week 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vicky Drapeau, PhD, RD, Laval University
- Principal Investigator: Angelo Tremblay, PhD, Laval University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 19, 2021
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
April 8, 2022
First Submitted That Met QC Criteria
June 9, 2022
First Posted (Actual)
June 14, 2022
Study Record Updates
Last Update Posted (Actual)
October 5, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAIRY-2019-397
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Low-fat dairy products
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Agroscope Liebefeld-Posieux Research Station ALPUniversity Hospital Inselspital, BerneCompletedInflammation | Obesity | Nutritional InterventionSwitzerland
-
Fred Hutchinson Cancer CenterUniversity of WashingtonCompletedInflammation | Obesity | Diabetes | Metabolic Syndrome | Insulin Resistance | NAFLDUnited States
-
Dairy Research InstituteBioFortis; Provident Clinical ResearchUnknownHypertensionUnited States
-
Midwest Center for Metabolic and Cardiovascular...National Dairy CouncilEnrolling by invitationOverweight and Obesity | Elevated TriglyceridesUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Joslin Diabetes CenterCompletedType 2 DiabetesUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Laval UniversityDairy Farmers of CanadaCompletedCardiovascular DiseaseCanada
-
University of ReadingMedical Research CouncilCompletedHypercholesterolemiaUnited Kingdom